BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7786918)

  • 21. Teboroxime, sestamibi and thallium-201 as markers of myocardial hypoperfusion: comparison by quantitative dual-isotope autoradiography in rabbits.
    Weinstein H; Reinhardt CP; Leppo JA
    J Nucl Med; 1993 Sep; 34(9):1510-7. PubMed ID: 8355072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison between myocardial perfusion scintigraphy with thallium-201 and technetium-99m-Sestamibi (methoxy isobutyl isonitrile) for the detection of coronary atherosclerotic disease].
    Taillefer R; Lambert R; Grégoire J; Essiambre R; Phaneuf DC
    Union Med Can; 1990; 119(6):322, 324, 326-9. PubMed ID: 2150134
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Planar myocardial perfusion imaging with technetium-99m-teboroxime: comparison by vascular territory with thallium-201 and coronary angiography.
    Dahlberg ST; Weinstein H; Hendel RC; McSherry B; Leppo JA
    J Nucl Med; 1992 Oct; 33(10):1783-8. PubMed ID: 1403145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Head-to-head comparison between technetium-99m-sestamibi and thallium-201 tomographic imaging for the detection of coronary artery disease using combined dipyridamole-exercise stress.
    Cramer MJ; Verzijlbergen JF; Van der Wall EE; Niemeyer MG; Zwinderman AH; Ascoop CA; Pauwels EJ
    Coron Artery Dis; 1994 Sep; 5(9):787-91. PubMed ID: 7858770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial perfusion imaging using technetium-99m radiopharmaceuticals.
    Kiat H; Berman DS; Maddahi J
    Radiol Clin North Am; 1993 Jul; 31(4):795-815. PubMed ID: 8337368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with technetium-99m teboroxime scintigraphy in patients referred for myocardial perfusion evaluation.
    Itti R; Bontemps L; Sayegh Y; Delmas O; Geronicola X; Andre-Fouët X
    Int J Card Imaging; 1992; 8(4):255-63. PubMed ID: 1464725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Thallium-201 and sestamibi: principles and kinetics of the two tracers].
    Parodi O
    G Ital Cardiol; 1991 Aug; 21(8):885-8. PubMed ID: 1837528
    [No Abstract]   [Full Text] [Related]  

  • 28. The VEX-test for myocardial scintigraphy with thallium-201 and sestamibi: effect on abdominal background activity.
    Hurwitz GA; Saddy S; O'Donoghue JP; Ali SA; Powe JE; Husni M; Gravelle DR
    J Nucl Med; 1995 Jun; 36(6):914-20. PubMed ID: 7769446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial perfusion imaging in ischemic heart disease anno 1990.
    Wackers FJ
    Curr Opin Cardiol; 1991 Aug; 6(4):590-601. PubMed ID: 10150064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Technetium-99m teboroxime scintigraphy. Clinical experience in patients referred for myocardial perfusion evaluation.
    Bontemps L; Geronicola-Trapali X; Sayegh Y; Delmas O; Itti R; André-Fouët X
    Eur J Nucl Med; 1991; 18(9):732-9. PubMed ID: 1936049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow.
    Glover DK; Ruiz M; Bergmann EE; Simanis JP; Smith WH; Watson DD; Beller GA
    J Nucl Med; 1995 Mar; 36(3):476-83. PubMed ID: 7884514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New agents labelled with technetium 99m for myocardial perfusion imaging.
    Taillefer R
    Can Assoc Radiol J; 1992 Aug; 43(4):258-66. PubMed ID: 1386280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thallium-201 and technetium-99m-sestamibi for assessing viable myocardium.
    Bonow RO; Dilsizian V
    J Nucl Med; 1992 May; 33(5):815-8. PubMed ID: 1533248
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative analysis of planar technetium-99m-sestamibi myocardial perfusion images using modified background subtraction.
    Koster K; Wackers FJ; Mattera JA; Fetterman RC
    J Nucl Med; 1990 Aug; 31(8):1400-8. PubMed ID: 2143529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy].
    Leoncini M; Sciagrà R; Bisi G; Santoro GM; Fazzini PF
    G Ital Cardiol; 1993 Feb; 23(2):127-38. PubMed ID: 8491353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [99mTc-Cardiolite and Tl-201 in the evaluation of myocardial blood flow. Comparison of their diagnostic usefulness].
    Gosiewska-Marcinkowska E
    Kardiol Pol; 1992; 36(1):18-23. PubMed ID: 1533887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detecting coronary artery disease using SPECT imaging: a comparison of thallium-201 and teboroxime.
    Fleming RM
    Am J Physiol Imaging; 1992; 7(1):20-3. PubMed ID: 1520504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine and dipyridamole myocardial scintigraphy.
    Iskandrian AS; Heo J
    J Nucl Biol Med (1991); 1992; 36(2 Suppl):73-81. PubMed ID: 1450250
    [No Abstract]   [Full Text] [Related]  

  • 39. [Evaluation of myocardial viability by isotopic methods].
    Latre Romero JM; Vallés Belsué F
    Rev Esp Cardiol; 1994; 47 Suppl 4():116-23. PubMed ID: 7863076
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing coronary artery disease with thallium-201 rest and technetium-99m-sestamibi stress testing at two centers.
    Meyers A; Ballow J; Topham L; Rainer R; Field C
    J Nucl Med Technol; 2000 Dec; 28(4):248-51. PubMed ID: 11142325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.